Ontology highlight
ABSTRACT:
SUBMITTER: Nishimura R
PROVIDER: S-EPMC5066655 | biostudies-literature | 2016 Jul
REPOSITORIES: biostudies-literature
Nishimura R R Omiya H H Sugio K K Ubukata M M Sakai S S Samukawa Y Y
Diabetes, obesity & metabolism 20160115 7
This randomized, double-blind, placebo-controlled, crossover study was the first to determine the effects of luseogliflozin in combination with a low-carbohydrate diet (LCD) on 24-h glucose variability, assessed by continuous glucose monitoring (CGM). A total of 18 Japanese patients with type 2 diabetes were randomized into two groups, in which patients first received luseogliflozin 2.5 mg once daily then placebo for 8 days each, or vice versa. Patients took luseogliflozin or placebo with a norm ...[more]